Literature DB >> 19321622

Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.

Thilo Hagen1.   

Abstract

The latency-associated nuclear antigen (LANA) of Karposi's sarcoma-associated herpesvirus has been reported to interact with glycogen synthase kinase 3beta (GSK-3beta) and regulate its activity, leading to inhibition of GSK-3-dependent beta-catenin degradation. In this study, the interaction between LANA and GSK-3beta was characterized further. LANA was found to interact with GSK-3beta in vitro as well as in intact cells. However, LANA did not regulate GSK-3beta kinase activity and LANA-induced upregulation of beta-catenin was GSK-3beta independent. LANA did not regulate the stability of beta-catenin or of its reported interaction partners p53 and von Hippel-Lindau protein. Additional targets of LANA are likely to mediate its malignancy-promoting function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321622      PMCID: PMC2687375          DOI: 10.1128/JVI.01671-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts.

Authors:  W J Ryves; L Fryer; T Dale; A J Harwood
Journal:  Anal Biochem       Date:  1998-11-01       Impact factor: 3.365

2.  Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.

Authors:  J Jonkers; H C Korswagen; D Acton; M Breuer; A Berns
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.

Authors:  Sharon Amit; Ada Hatzubai; Yaara Birman; Jens S Andersen; Etti Ben-Shushan; Matthias Mann; Yinon Ben-Neriah; Irit Alkalay
Journal:  Genes Dev       Date:  2002-05-01       Impact factor: 11.361

4.  GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.

Authors:  A A Culbert; M J Brown; S Frame; T Hagen; D A Cross; B Bax; A D Reith
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

5.  Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.

Authors:  Chunming Liu; Yiming Li; Mikhail Semenov; Chun Han; Gyeong Hun Baeg; Yi Tan; Zhuohua Zhang; Xinhua Lin; Xi He
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

6.  A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Masahiro Fujimuro; Frederick Y Wu; Colette ApRhys; Henry Kajumbula; David B Young; Gary S Hayward; S Diane Hayward
Journal:  Nat Med       Date:  2003-02-18       Impact factor: 53.440

7.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.

Authors:  Masahiro Fujimuro; S Diane Hayward
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis.

Authors:  C Yost; G H Farr; S B Pierce; D M Ferkey; M M Chen; D Kimelman
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

9.  A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.

Authors:  Qiliang Cai; Masanao Murakami; Huaxin Si; Erle S Robertson
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

10.  The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.

Authors:  Jianyong Liu; Heather J Martin; Gangling Liao; S Diane Hayward
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

View more
  5 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.

Authors:  Jie Lu; Subhash C Verma; Qiliang Cai; Erle S Robertson
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

3.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 4 (vIRF4) Perturbs the G1-S Cell Cycle Progression via Deregulation of the cyclin D1 Gene.

Authors:  Hye-Ra Lee; Jaba Mitra; Stacy Lee; Shou-Jiang Gao; Tae-Kwang Oh; Myung Hee Kim; Taekjip Ha; Jae U Jung
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

4.  Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation.

Authors:  Fengchun Ye; Xiufen Lei; Shou-Jiang Gao
Journal:  Adv Virol       Date:  2011

5.  Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHV.

Authors:  Mel Campbell; Yoshihiro Izumiya
Journal:  Front Microbiol       Date:  2012-02-14       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.